Alaunos Therapeutics, Inc. Income Taxes Paid
Alaunos Therapeutics, Inc. (TCRT) reported Income Taxes Paid of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-05.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2019-03-05
- Alaunos Therapeutics, Inc. income taxes paid, net for the quarter ending 2018-12-31 was $0.00.
- Alaunos Therapeutics, Inc. income taxes paid, net for the quarter ending 2018-09-30 was $0.00.
- Alaunos Therapeutics, Inc. income taxes paid, net for the quarter ending 2017-12-31 was $0.00.
- Alaunos Therapeutics, Inc. income taxes paid, net for the quarter ending 2017-09-30 was $0.00.
- Alaunos Therapeutics, Inc. income taxes paid, net for fiscal 2018 was $0.00.
- Alaunos Therapeutics, Inc. income taxes paid, net for fiscal 2017 was $0.00.
- Alaunos Therapeutics, Inc. income taxes paid, net for fiscal 2016 was $0.00.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $0.00 derived: sum of 2 quarters · filed 2019-03-05 | $0.00 10-K · filed 2019-03-05 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | ||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $0.00 derived: sum of 2 quarters · filed 2019-03-05 | $0.00 10-K · filed 2019-03-05 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-08 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |